Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02310880 · ClinicalTrials.gov registry record

Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World

A clinical trial of Low Vision, sponsored by University of Alabama at Birmingham.

Completed
Registry status
35
Enrollment target
1
Study location

NCT02310880: Completed study of Low Vision, sponsored by University of Alabama at Birmingham.

NCT02310880 is a study of Low Vision that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 35 participants, below the 417-participant average among 8 other Low Vision trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02310880, a study of Low Vision, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
35 participants
Enrollment target
1
Study location

Study Summary

Low vision patients have difficulty acquiring sufficient visual information in a timely manner for the purpose of performing challenging daily tasks, such as traveling independently and safely through busy streets. The advance of virtual reality techniques has provided a potential platform for training low vision patients to use their remaining vision more efficiently, but the key issue is always whether the patient's visual experiences in a virtual world can be transferred to the real world. The proposed study is designed to provide definite answer to this question.

Primary Outcome

The percentage of dangerous street crossing decisions is determined at real street corners during pre- and post-training evaluation sessions. The subject is asked to say "GO" when she feels it is the safest time to cross the street. A crossing decision is scored as dangerous if it is initiated in the red traffic light cycle or if there is \< 25% of the "WALK" cycle left. The percentage is the total number of dangerous decisions divided by the total number of crossing decisions made during one ev

Conditions Studied

Study Locations (1)

Alabama

  • The Clinical Eye Research Facility - Birmingham

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2010-09
Est. Completion 2015-03
University of Alabama at Birmingham

1,160 total trials

What the finished NCT02310880 record still lists

NCT02310880 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 417-participant average among 8 other Low Vision trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Low Vision appearing as the primary indexed condition, and to 0 interventions.

NCT02310880 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT02310880 about?

NCT02310880 is a clinical study titled "Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World". Low vision patients have difficulty acquiring sufficient visual information in a timely manner for the purpose of performing challenging daily tasks, such as traveling independently and safely through busy streets. The advance of virtual reality techniques has provided a potential platform for train...

What is the current status of trial NCT02310880?

This trial is currently completed. The enrollment target is 35 participants. The study started on 2010-09. Estimated completion is 2015-03.

What conditions does trial NCT02310880 study?

This clinical trial studies the following conditions: Low Vision.

Who is sponsoring clinical trial NCT02310880?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02310880 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Vision

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02310880's enrollment target sits among peer trials

35 6th of 8 higher than 3 of 8 other Low Vision trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Low Vision trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02310880, the US trial registry maintained by the National Library of Medicine. NCT02310880 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.